Micro-cap moonshot picks from stkmrkt intelligence — 162 names currently reviewed · Updated
Theses, risks and catalysts on each pick are drafted by stkmrkt's AI and ranked by our quantitative model.
⚠ High-Risk, Speculative Picks
Diamond Finder surfaces speculative micro/nano-cap stocks with low liquidity, high volatility, and real dilution risk. These names can and do go to zero — possible total loss of any amount invested. Nothing here is financial advice; conviction scores and predicted multiples are model outputs, not guarantees. Always do your own research and size positions accordingly.
Rank Correlation
-0.15
Top-Quartile Hit Rate
49.8%
Bottom-Quartile Hit Rate
—
Sample Size
578
Evaluated Aug 25, 2026 → Sep 24, 2026 (30-day lookback)
Based on 6 daily evaluations — a short history; treat with appropriate caution.
Moonshot picks like these feed into stkmrkt's own $100K AI Challenge portfolio — see how they're performing live.
See AI Challenge →NASDAQ
"Strong 27% YoY revenue growth and 63.4% operating margins with consensus score 5"
Price
$1.35
Predicted Multiple
4.24x reward
Ann. Volatility
288.6% high risk
Avg $ Volume
$396K low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Technology · NASDAQ
"NXTT's $159M cash and 5,833 BTC ($500M value) are undervalued relative to its $0.05B market cap."
Price
$5.67
Predicted Multiple
4.13x reward
Ann. Volatility
139.8% high risk
Avg $ Volume
$402K low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Healthcare · NASDAQ
"$4.60/share net cash runway enables critical human study #7 readouts without dilution."
Price
$3.37
Predicted Multiple
4.02x reward
Ann. Volatility
265.7% high risk
Avg $ Volume
$927K low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Technology · NASDAQ
"Low float (1.3M shares) combined with retail enthusiasm creating a potential short squeeze catalyst."
Price
$3.05
Predicted Multiple
3.85x reward
Ann. Volatility
1688.3% high risk
Avg $ Volume
$3.50M low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Healthcare · NASDAQ
"Tiny float (387K shares) combined with unsustainable 463% short borrow fees creates high probability of short squeeze and catalyst."
Price
$1.99
Predicted Multiple
3.79x reward
Ann. Volatility
134.5% high risk
Avg $ Volume
$1.98M low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Healthcare · NASDAQ
"G3 acquisition catalyst could unlock revenue despite 2467.8% 3m momentum"
Price
$3.03
Predicted Multiple
4.30x reward
Ann. Volatility
247.5% high risk
Avg $ Volume
$12.72M low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Energy · NASDAQ
"STAK's 57.1% short interest and 7M float create potential for short squeeze momentum."
Price
$1.44
Predicted Multiple
4.05x reward
Ann. Volatility
162.9% high risk
Avg $ Volume
$3.47M low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Industrials · NASDAQ
"45.5% operating margin and 0.008 debt/equity ratio support recovery foundation."
Price
$1.12
Predicted Multiple
3.92x reward
Ann. Volatility
141.7% high risk
Avg $ Volume
$2.80M low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Healthcare · NASDAQ
"Analyst consensus (consensus_score >= 4.0) AND model tier AND momentum all align → strong moonshot signal."
Price
$1.70
Predicted Multiple
3.90x reward
Ann. Volatility
129.4% high risk
Avg $ Volume
$169K low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Healthcare · NASDAQ
"Perceived low float (600k shares) enabling rapid price appreciation on minimal volume."
Price
$5.17
Predicted Multiple
3.87x reward
Ann. Volatility
814.7% high risk
Avg $ Volume
$9.96M low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Technology · NASDAQ
"Low float (980K shares) combined with institutional interest and conference catalyst could trigger a short squeeze, driving price targets to $2.50-$3.00."
Price
$4.73
Predicted Multiple
3.79x reward
Ann. Volatility
406.6% high risk
Avg $ Volume
$3.34M low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Technology · NASDAQ
"Speculation around the $3.17M BTC PIPE deal closing by Sept 14, 2026, driving short-term price momentum."
Price
$1.67
Predicted Multiple
3.78x reward
Ann. Volatility
168.6% high risk
Avg $ Volume
$825K low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Communication Services · NASDAQ
"Short squeeze momentum and retail bullish sentiment driving price targets to $2.50-$3.00, amplified by after-hours volume."
Price
$1.44
Predicted Multiple
3.77x reward
Ann. Volatility
90.7% high risk
Avg $ Volume
$2.36M low liquidity risk
Conviction band hit-rate
2x 74.8% · 5x 40.7% · 10x 20.4% · 20x 9.3%
Band-level historical rate, not a per-stock probability.
Technology · NASDAQ
"Strong analyst consensus (score 5), low short float (1.1%), and 19.5% 3-month momentum suggest short-covering catalyst."
Price
$0.74
Predicted Multiple
3.35x reward
Ann. Volatility
201.4% high risk
Avg $ Volume
$3.15M low liquidity risk
Conviction band hit-rate
2x 65.3% · 5x 24.0% · 10x 8.5% · 20x 2.5%
Band-level historical rate, not a per-stock probability.
Healthcare · NASDAQ
"FDA approval catalyst with 100% analyst buy rating and 994.9% upside target."
Price
$0.91
Predicted Multiple
3.27x reward
Ann. Volatility
136.8% high risk
Avg $ Volume
$4.41M low liquidity risk
Conviction band hit-rate
2x 65.3% · 5x 24.0% · 10x 8.5% · 20x 2.5%
Band-level historical rate, not a per-stock probability.
Healthcare · NASDAQ
"Phase 2b trial data showing statistically significant 6-minute walk improvement (p=0.0077) validates key metric."
Price
$2.91
Predicted Multiple
3.65x reward
Ann. Volatility
863.2% high risk
Avg $ Volume
$678K low liquidity risk
Conviction band hit-rate
2x 65.3% · 5x 24.0% · 10x 8.5% · 20x 2.5%
Band-level historical rate, not a per-stock probability.
Healthcare · NASDAQ
"FDA approval catalyst with strong analyst consensus (4.2/5) and 564.2% 3-month momentum."
Price
$3.17
Predicted Multiple
3.42x reward
Ann. Volatility
115.1% high risk
Avg $ Volume
$2.26M low liquidity risk
Conviction band hit-rate
2x 65.3% · 5x 24.0% · 10x 8.5% · 20x 2.5%
Band-level historical rate, not a per-stock probability.
Healthcare · NASDAQ
"Avoiding Nasdaq delisting via $5M market cap requirement by Sept 16, 2026, could drive 327% 3-month momentum surge."
Price
$0.88
Predicted Multiple
3.37x reward
Ann. Volatility
44.4% high risk
Avg $ Volume
$171K low liquidity risk
Conviction band hit-rate
2x 65.3% · 5x 24.0% · 10x 8.5% · 20x 2.5%
Band-level historical rate, not a per-stock probability.
Technology · NASDAQ
"Explosive 416.8% 3-month momentum and $3M strategic investment catalyst align with AI bullish sentiment (conviction 7)."
Price
$2.06
Predicted Multiple
3.33x reward
Ann. Volatility
36.3% high risk
Avg $ Volume
$82K low liquidity risk
Conviction band hit-rate
2x 65.3% · 5x 24.0% · 10x 8.5% · 20x 2.5%
Band-level historical rate, not a per-stock probability.
Financial Services · NYSE
"AI bullish sentiment (conviction 7) and 337.4% analyst upside align with 875.5% 3m momentum."
Price
$2.03
Predicted Multiple
3.32x reward
Ann. Volatility
171.5% high risk
Avg $ Volume
$1.16M low liquidity risk
Conviction band hit-rate
2x 65.3% · 5x 24.0% · 10x 8.5% · 20x 2.5%
Band-level historical rate, not a per-stock probability.
Healthcare · NASDAQ
"4.0 analyst consensus score and 920.8% upside target reflect sector momentum (13.7% 1m)."
Price
$0.38
Predicted Multiple
3.29x reward
Ann. Volatility
97.0% high risk
Avg $ Volume
$1.09M low liquidity risk
Conviction band hit-rate
2x 65.3% · 5x 24.0% · 10x 8.5% · 20x 2.5%
Band-level historical rate, not a per-stock probability.
Technology · NASDAQ
"422.6% 3-month momentum and 1168.5% analyst upside with sector momentum."
Price
$1.62
Predicted Multiple
3.25x reward
Ann. Volatility
47.2% high risk
Avg $ Volume
$2.13M low liquidity risk
Conviction band hit-rate
2x 65.3% · 5x 24.0% · 10x 8.5% · 20x 2.5%
Band-level historical rate, not a per-stock probability.
Healthcare · NASDAQ
"Positive Annamycin trial results could trigger a 10x+ price surge if FDA approval follows."
Price
$0.57
Predicted Multiple
3.23x reward
Ann. Volatility
176.2% high risk
Avg $ Volume
$675K low liquidity risk
Conviction band hit-rate
2x 65.3% · 5x 24.0% · 10x 8.5% · 20x 2.5%
Band-level historical rate, not a per-stock probability.
Healthcare · AMEX
"Strong analyst consensus (4.4/5.0) and partnership catalyst for ABP-450 driving 468.8% upside."
Price
$0.26
Predicted Multiple
3.22x reward
Ann. Volatility
145.7% high risk
Avg $ Volume
$3.61M low liquidity risk
Conviction band hit-rate
2x 65.3% · 5x 24.0% · 10x 8.5% · 20x 2.5%
Band-level historical rate, not a per-stock probability.
Every night, Diamond Finder's quantitative model scores thousands of stocks on momentum, realized volatility, and liquidity, looking for the structural profile that has historically preceded large multi-bagger moves in small, speculative companies. The highest-scoring names are then reviewed by stkmrkt intelligence, which writes a thesis, a list of risks, and the catalysts it's watching for — only names it actually endorses ("moonshot" or "watch") appear in the default list above; names it rejects are never shown as picks.
Want the full breakdown, including what "moonshot" actually means and how it differs from a typical growth stock? Read What Is a Moonshot Stock?
In the most recent evaluation (2026-09-25, 578 scored stocks), 49.8% of Diamond Finder's top-quartile names beat the median 30-day forward return, and the rank correlation between conviction and realized return was -0.1479 — meaning no demonstrated predictive edge yet. That's based on 6 daily evaluations so far.
Price and volume data are daily bars from Yahoo Finance; analyst data is aggregated from public sources. Scores refresh after each nightly scan; this page reflects the scan for . Diamond Finder is a research screen, not investment advice.